Us Polymerase Chain Reaction Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 11,168.47 |
 CAGR |
% |
| Major Markets Players |
>美国聚合酶链反应市场，按产品类型（试剂、仪器、消耗品、软件和服务）、方法（实时 PCR、逆转录 (RT) PCR、常规 PCR、多重 PCR、嵌套 PCR、热启动 PCR、长距离 PCR、组装 PCR、反向 PCR 等）、应用（临床、生命科学和相关研究、法医科学、环境微生物学等）、最终用户（制药和生物技术公司、医院和诊所、诊断实验室、学术和研究组织、法医实验室、参考实验室等）、分销渠道（直接招标、零售销售等）- 行业趋势和预测到 2030 年。
美国聚合酶链反应市场分析和规模
由于市场参与者数量的增加和先进技术诊断设备的可用性，美国聚合酶链反应市场预计将在预测年内增长。先进技术领域的不断发展有望进一步推动市场增长。然而，治疗药物和诊断及手术用医疗器械的生产和商业化严格监管等困难预计将在预测期内抑制市场增长。
Data Bridge Market Research 分析称，美国聚合酶链反应市场预计到 2030 年将达到 111.6847 亿美元，预测期内复合年增长率为 12.2%。本市场报告还深入介绍了定价分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品类型（试剂、仪器、耗材、软件和服务）、方法（实时 PCR、逆转录 (RT) PCR、常规 PCR、多重 PCR、嵌套 PCR、热启动 PCR、长距离 PCR、组装 PCR、反向 PCR 等）、应用（临床、生命科学及相关研究、法医科学、环境微生物学等）、最终用户（制药和生物技术公司、医院和诊所、诊断实验室、学术和研究组织、法医实验室、参考实验室等）、分销渠道（直接招标、零售等） |
|
覆盖国家 |
我们 |
|
涵盖的市场参与者 |
Beckman Coulter, Inc、F. Hoffmann-La Roche Ltd、Promega Corporation、Illumina, Inc、Bio-Rad Laboratories, Inc、QIAGEN、Merck KGaA、GenScript、Thermo Fisher Scientific Inc、PerkinElmer Inc、Enzo Life Sciences, Inc.、bioMérieux Inc、Takara Bio Inc.、LGC biosearch technologies、Meridian bioscience, Inc.、luminex corporation 和 Agilent Technologies, Inc 等 |
市场定义
聚合酶链式反应 (PCR) 是一种广泛用于快速复制数百万至数十亿个特定 DNA 样本的方法，它使科学家能够充分扩增非常小的 DNA 样本或其中的一部分，以便进行详细研究。它是一种用于快速准确地复制特定 DNA 片段的技术。PCR 基于利用 DNA 聚合酶合成与提供的模板链互补的新 DNA 链的能力。大多数 PCR 方法依赖于热循环。热循环将反应物暴露于反复的加热和冷却循环中，以允许不同的温度依赖性反应 - 具体来说，DNA 熔化和酶驱动的 DNA 复制。
美国聚合酶链反应市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
司机
- PCR 诊断可用性的提高
聚合酶链式反应是现代生物学中最广泛使用的技术之一。PCR 是基于一种体外扩增分子技术，可产生 DNA 链中特定区域的数百万份拷贝。PCR 设备的可用性和采用率的提高是由于它可以诊断各种疾病并快速获得结果。PCR 是一种简单且广泛使用的过程，其中可以将微量的 DNA 扩增成多个拷贝。除了这种检测方法的快速性之外，它还可以定量显示特定序列的存在量。
例如，
- 2020 年 8 月，根据国家人类基因组研究所的数据，PCR 可用性的提高是由于一种用于扩增小片段 DNA 的快速廉价技术。该技术的可用性正在提高，因为它快速、准确且可扩展，使其成为大规模病毒检测的理想选择
因此，增加 PCR 仪器和试剂的产量也提高了产品可用性的效率，因此，PCR 诊断可用性的提高有望推动市场的增长。
- PCR 的应用日益广泛
PCR 具有许多研究和实际应用。PCR 已常规用于 DNA 克隆、医学诊断和 DNA 法医分析。PCR 技术已成为牙科领域的标准诊断和研究工具。PCR 和其他分子生物学技术可以诊断引起颌面部感染的感染性微生物。这有助于有效管理牙周病、龋齿、口腔癌和牙髓感染等疾病。
例如，
- 2023 年 5 月，根据 NCBI 文章，PCR 是迄今为止最发达的分子技术，具有广泛的已实现和潜在的临床应用，包括特定或广谱病原体检测、新发感染的评估、监测、生物威胁因子的早期检测
因此，总而言之，PCR 的不断增长的应用有望推动市场的增长。
机会
- 政府采取措施实施各种疾病筛查计划
全球疾病负担持续加重，给卫生系统、家庭和个人带来巨大的经济、情感和身体压力。在医疗体系强大的国家，由于优质护理、意识增强和早期检测方便，许多疾病（如癌症）的存活率得到提高。据美国疾病控制和预防中心称，美国太平洋岛屿和领土通过国家综合癌症控制计划 (NCCCP) 适应组建或支持联盟，以对抗其社区中的癌症，从而提高了人们对肺癌筛查计划的认识，并使用 PCR 诊断进行早期检测，因为 PCR 可以扩增 DNA 片段，发现和诊断与癌症相关的遗传病或疾病。
例如，
- 2021 年 3 月，根据 NCBI 文章，政府指示应对医护人员进行 covid-19 筛查计划，因为他们的感染风险很高，并且 由于在职业中接触病人和被病毒污染的表面，他们可能面临更大的新发传染病风险
政府越来越多地推出针对各种疾病的筛查计划，预计将为市场增长带来机遇。
克制/挑战
- 分析新型复杂设备的局限性
分析复杂的医疗设备需要了解设备的使用环境、工作量和使用环境。实验室使用的新产品的复杂性由多种因素造成。在开发过程的早期，工作人员和设备制造商之间的持续互动非常必要，并且必须了解这些互动才能操作部件或整体设置。由于 PCR 诊断的技术挑战越来越复杂，因为技术进步由一组异构的、新颖且截然不同的技术组成。
近年来，人工智能/机器学习在医疗器械中的应用越来越广泛，尤其是对于需要分析大量数据或解释复杂信息的任务。机器、工具和设备等新型复杂产品的检测和分析的局限性阻碍了美国聚合酶链反应市场的增长。
最新动态
- 2022 年 2 月，赛默飞世尔科技公司宣布推出一种新的快速环境检测方法，以帮助对抗 COVID-19。Thermo Scientific Renvo 快速 PCR 检测是该公司空气病原体监测产品组合中的最新解决方案。Renvo 快速 PCR 检测是针对使用该公司的 Thermo Scientific AerosolSense 采样器收集的空气样本进行的。这有助于该组织创造更多收入
- 2020 年 3 月，Bio-Rad Laboratories, Inc. 宣布其实时 qPCR 产品正被全球检测实验室用于筛查 COVID-19。这有助于该组织提高整体收入
美国聚合酶链反应市场范围
美国聚合酶链反应市场根据产品类型、方法、应用、最终用户和分销渠道分为五个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品类型
- 试剂
- 仪器
- 耗材
- 软件和服务
根据产品类型，市场分为试剂、仪器、消耗品、软件和服务。
方法
- 实时 PCR
- 逆转录（RT）PCR
- 常规 PCR
- 多重PCR
- 嵌套PCR
- 热启动 PCR
- 长距离PCR
- 组装PCR
- 反向 PCR
- 其他的
根据方法，市场分为实时 PCR、逆转录 (RT) PCR、常规 PCR、多重 PCR、嵌套 PCR、热启动 PCR、长距离 PCR、组装 PCR、反向 PCR 等。
按应用
- 临床
- 生命科学及相关研究
- 法医学
- 环境微生物学
- 其他
根据应用，市场分为临床、生命科学和相关研究、法医科学、环境微生物学等。
按最终用户
- 制药和生物技术公司
- 医院和诊所
- 诊断实验室
- 学术及研究机构
- 法医实验室
- 参考实验室
- 其他的
根据最终用户，市场分为制药和生物技术公司、医院和诊所、诊断实验室、学术和研究组织、法医实验室、参考实验室等。
按分销渠道
- 直接招标
- 零售销售
- 其他的
根据分销渠道，市场分为直接招标、零售销售和其他。
竞争格局和美国聚合酶链反应市场份额分析
美国聚合酶链反应市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
美国聚合酶链反应市场的一些主要市场参与者包括 Beckman Coulter, Inc、F. Hoffmann-La Roche Ltd、Promega Corporation、Illumina, Inc、Bio-Rad Laboratories, Inc、QIAGEN、Merck KGaA、GenScript、Thermo Fisher Scientific Inc、PerkinElmer Inc、Enzo Life Sciences, Inc.、bioMérieux Inc、Takara Bio Inc.、LGC biosearch technologies、Meridian bioscience, Inc.、luminex corporation 和 Agilent Technologies, Inc 等
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. POLYMERASE CHAIN REACTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 INSTALLATION BASE
4.4 COST ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 HEALTHCARE ECONOMY
4.6.1 HEALTHCARE EXPENDITURE
4.6.2 CAPITAL EXPENDITURE
4.6.3 CAPEX TRENDS
4.6.4 CAPEX ALLOCATIONS
4.6.5 FUNDING SOURCES
4.6.6 INDUSTRY BENCHMARKS
4.6.7 GDP RATIO IN OVERALL GDP
4.6.8 HEALTHCARE SYSTEM STRUCTURE
4.6.9 GOVERNMENT POLICIES
4.6.10 ECONOMIC DEVELOPMENT
4.7 INDUSTRY INSIGHTS
4.7.1 MICRO AND MACROECONOMIC FACTORS
4.7.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.7.3 KEY PRICING STRATEGIES
4.8 TECHNOLOGY ROADMAP
5 REGULATORY COMPLIANCE
5.1 REGULATORY AUTHORITIES
5.2 REGULATORY CLASSIFICATIONS
5.3 REGULATORY SUBMISSIONS
5.4 INTERNATIONAL HARMONIZATION
5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO
5.6 REGULATORY CHALLENGES AND STRATEGY
6 MARKET OVERVIEW, U.S. POLYMERASE CHAIN REACTION MARKET
6.1 DRIVERS
6.1.1 RISE IN THE AVAILABILITY OF PCR DIAGNOSTICS
6.1.2 INCREASING APPLICATION OF PCR
6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE
6.2 RESTRAINTS
6.2.1 LIMITATIONS WHILE ANALYZING THE NOVEL COMPLEX DEVICE
6.2.2 LONG APPROVAL PROCEDURE
6.3 OPPORTUNITIES
6.3.1 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 INCREASE IN THE PRODUCT RECALLS
6.4.2 HIGH COST OF PCR MEDICAL DEVICE DEVELOPMENT
7 U.S. POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 REAGENTS
7.2.1 DNA OR PCR TEMPLATES
7.2.2 DNA POLYMERASE I ENZYME
7.2.2.1 TAQ DNA POLYMERASE
7.2.2.2 HIGH-FIDELITY DNA POLYMERASE
7.2.2.3 GREEN TAQ DNA POLYMERASE
7.2.2.4 HOT START TAQ DNA POLYMERASE
7.2.2.5 PROOFREADING DNA POLYMERASE
7.2.2.6 OTHERS
7.2.3 PRIMERS
7.2.4 DEOXYNUCLEOTIDE TRIPHOSPHATES (DNTPS)
7.2.5 PCR BUFFERS
7.2.5.1 TRIS-HCL
7.2.5.2 POTASSIUM CHLORIDE (KCL)
7.2.5.3 MAGNESIUM CHLORIDE
7.2.6 MASTER MIX OR PCR KIT
7.2.7 PROBES
7.2.8 ANTI-TAQ DNA POLYMERASE ANTIBODY
7.2.9 DIGITAL PCR SUPERMIXES
7.2.10 OTHERS
7.3 INSTRUMENTS
7.3.1 BY TYPE
7.3.1.1 DIGITAL PCR
7.3.1.1.1 DIGITAL PCR(DDPCR)
7.3.1.1.2 CHIP BASED DIGITAL PCR
7.3.1.1.3 BEAMING DIGITAL PCR
7.3.1.2 REAL TIME PCR
7.3.1.3 CONVENTIONAL PCR
7.3.1.4 OTHERS
7.3.2 BY MODALITY
7.3.2.1 STANDLONE
7.3.2.2 HANDHELD
7.3.2.3 PORTABLE
7.4 CONSUMABLES
7.4.1 PCR TUBES AND CAPS
7.4.2 PCR STRIPS
7.4.3 PCR WELL PLATES
7.4.4 STRIP TUBES
7.4.5 PLATE SEALS
7.4.6 CARTRIDGES AND GASKETS
7.4.7 OTHERS
7.5 SOFTWARE AND SERVICES
8 U.S. POLYMERASE CHAIN REACTION MARKET, BY METHOD
8.1 OVERVIEW
8.2 REAL-TIME PCR
8.3 REVERSE-TRANSCRIPTASE(RT) PCR
8.4 CONVENTIONAL PCR
8.5 MULTIPLEX PCR
8.6 NESTED PCR
8.7 HOT START PCR
8.8 LONG-RANGE PCR
8.9 ASSEMBLY PCR
8.1 INVERSE PCR
8.11 OTHERS
9 U.S. POLYMERASE CHAIN REACTION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL
9.2.1 ONCOLOGY TESTING
9.2.2 INFECTIOUS DISEASE TESTING
9.2.2.1 HUMAN PAPILLOMAVIRUS
9.2.2.2 HIV
9.2.2.3 HCV
9.2.2.4 HEPATITIS B VIRUS
9.2.2.5 OTHERS
9.2.3 TRANSPLANT DIAGNOSTICS
9.2.4 PATERNITY TESTING
9.2.5 OTHERS
9.3 LIFE SCIENCE AND RELATED RESEARCHES
9.3.1 MICROBIOLOGY
9.3.2 MOLECULAR AND CELL BIOLOGY
9.3.3 OTHERS
9.4 FORENSIC SCIENCE
9.4.1 DNA TYPING
9.4.2 DNA TESTING
9.4.3 GENETIC FINGERPRINTING
9.5 ENVIRONMENTAL MICROBIOLOGY
9.5.1 DETECTION OF TARGETED MICROORGANISMS
9.5.2 QUANTIFICATION OF MICROBIAL POPULATION
9.5.3 MICROBIAL COMMUNITY ANALYSIS
9.5.4 DETECTION OF MICROBIAL PATHOGEN
9.5.5 DETECTION OF GENE EXPRESSION IN THE ENVIRONMENT
9.5.6 DETECTION OF INDICTOR MICROORGANISMS IN WATER
9.5.7 ENVIRONMENTAL DNA ANALYSIS
9.5.8 OTHERS
9.6 OTHERS
10 U.S. POLYMERASE CHAIN REACTION MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3 HOSPITALS AND CLINICS
10.3.1 PRIVATE
10.3.1.1 TIER 1
10.3.1.2 TIER 2
10.3.1.3 TIER 3
10.3.2 PUBLIC
10.3.2.1 TIER 1
10.3.2.2 TIER 2
10.3.2.3 TIER 3
10.4 DIAGNOSTIC LABORATORIES
10.5 ACADEMIC AND RESEARCH ORGANIZATIONS
10.6 FORENSIC LABORATORIES
10.7 REFERENCE LABORATORIES
10.8 OTHERS
11 U.S. POLYMERASE CHAIN REACTION MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 OTHERS
12 U.S. POLYMERASE CHAIN REACTION MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: U.S.
13 SWOT ANALYSIS
14 U.S. POLYMERASE CHAIN REACTION MARKET, COMPANY PROFILE
14.1 MERCK KGAA
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 F. HOFFMANN- LA ROCHE LTD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 BIO-RAD LABORATORIES, INC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 QIAGEN
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 AGILENT TECHNOLOGIES, INC.
14.5.1 COMPANY PROFILE
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 ABBOTT
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 BECKMAN COULTER, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIOMERIUX
14.8.1 COMPANY PROFILE
14.8.2 REVENUE ANALYSIS
14.8.4 RECENT DEVELOPMENT
14.9 ENZO LIFE SCIENCES, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 GENSCRIPT
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 ILLUMINA INC
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENT
14.12 LGC BIOSEARCH TECHNOLOGIES
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 LUMINEX CORPORATION
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 MERIDIAN BIOSCIENCE INC
14.14.1 COMPANY PROFILE
14.14.2 REVENUE ANALYSIS
14.14.4 RECENT DEVELOPMENT
14.15 PERKINELMER INC
14.15.1 COMPANY PROFILE
14.15.2 REVENUE ANALYSIS
14.15.4 RECENT DEVELOPMENT
14.16 PROMEGA CORPORATION
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 TAKARA BIO INC
14.17.1 COMPANY PROFILE
14.17.2 REVENUE ANALYSIS
14.17.4 RECENT DEVELOPMENT
14.18 THERMO FISHER SCIENTIFIC
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
TABLE 1 U.S. POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 U.S. REAGENTS IN POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 3 U.S. DNA POLYMERASE I ENZYME IN POLYMERASE CHAIN REACTION MARKET, BY REAGENTS, 2021-2030 (USD MILLION)
TABLE 4 U.S. PCR BUFFERS IN POLYMERASE CHAIN REACTION MARKET, BY REAGENTS, 2021-2030 (USD MILLION)
TABLE 5 U.S. INSTRUMENTS IN POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 U.S. DIGITAL PCR IN POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 7 U.S. INSTRUMENTS IN POLYMERASE CHAIN REACTION MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 8 U.S. CONSUMABLES IN POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 U.S. POLYMERASE CHAIN REACTION MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 10 U.S. POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 11 U.S. CLINICAL IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 U.S. INFECTIOUS DISEASE TESTING IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 13 U.S. LIFE SCIENCE AND RELATED RESEARCHES IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 U.S. FORENSIC SCIENCE IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 15 U.S. ENVIRONMENTAL MICROBIOLOGY IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 U.S. POLYMERASE CHAIN REACTION MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 17 U.S. HOSPITALS AND CLINICS IN POLYMERASE CHAIN REACTION MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 18 U.S. PRIVATE IN POLYMERASE CHAIN REACTION MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 19 U.S. PUBLIC IN POLYMERASE CHAIN REACTION MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 20 U.S. POLYMERASE CHAIN REACTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
图片列表
FIGURE 1 U.S. POLYMERASE CHAIN REACTION MARKET: SEGMENTATION
FIGURE 2 U.S. POLYMERASE CHAIN REACTION MARKET: DATA TRIANGULATION
FIGURE 3 U.S. POLYMERASE CHAIN REACTION MARKET: DROC ANALYSIS
FIGURE 4 U.S. POLYMERASE CHAIN REACTION MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 U.S. POLYMERASE CHAIN REACTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. POLYMERASE CHAIN REACTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. POLYMERASE CHAIN REACTION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 U.S. POLYMERASE CHAIN REACTION MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 U.S. POLYMERASE CHAIN REACTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 U.S. POLYMERASE CHAIN REACTION MARKET: SEGMENTATION
FIGURE 11 INCREASING APPLICATION OF PCR IS EXPECTED TO DRIVE THE GROWTH OF THE U.S. POLYMERASE CHAIN REACTION MARKET IN THE FORECAST PERIOD
FIGURE 12 THE REAGENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. POLYMERASE CHAIN REACTION MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE U.S. POLYMERASE CHAIN REACTION MARKET
FIGURE 14 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, 2022
FIGURE 19 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, 2023-2030 (USD MILLION)
FIGURE 20 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, CAGR (2023-2030)
FIGURE 21 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 22 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, 2022
FIGURE 23 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, 2022
FIGURE 27 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 U.S. POLYMERASE CHAIN REACTION MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
